Two Closures, Months Apart
Back in Part 4, I reported that CDC had declared the Cyclospora/iceberg lettuce outbreak over on September 11, 2026 — final numbers were 11,458 illnesses, 20 states, 495 hospitalizations, and 2 deaths, tied to shredded iceberg lettuce from Taylor Farms de Mexico. That was CDC closing the epidemiological side of things. FDA runs a separate track — the traceback and environmental investigation — and that one just closed on October 2, 2026, three weeks later. FDA's notice is clear that it will keep working on post-outbreak response even though the investigation itself is done.
What the Traceback Actually Found
This is the part that's actually new information, not just a status update. FDA's traceback identified several farms and a processing facility in Mexico that supplied the recalled lettuce, and FDA investigators conducted onsite inspections there in coordination with Mexican officials — observing operations, reviewing records, and collecting samples of water, soil, sediment, and lettuce itself.
Of everything collected, two samples tested positive for Cyclospora: one from a tank holding outgoing wastewater at the Taylor Farms de Mexico processing facility, and one from a drainage ditch at an iceberg lettuce grower identified through the traceback. FDA has completed genotyping on both positive environmental samples and is still comparing those results to the genotyping done on samples from sick people.
What this does and doesn't prove: FDA is careful to say there isn't yet enough evidence to conclusively determine exactly how the contamination happened. But finding the actual parasite in the water and soil where the lettuce was grown and processed is a meaningfully stronger finding than epidemiology and traceback alone — it's physical confirmation that Cyclospora was present in the right place at the right time, not just a statistical association. FDA says it remains confident that all recalled lettuce tied to this specific outbreak is off the market.
FDA's 10-Point Plan Before Next Season
On the same day it closed the lettuce investigation, FDA also announced a separate set of 10 planned activities aimed at preventing a repeat of this year's run of Cyclospora outbreaks — to be carried out between now and the start of the 2027 growing season. The headline items: a forthcoming Outbreak Investigation Report summarizing this whole investigation with formal recommendations, increased surveillance of the specific commodities that have historically been linked to Cyclospora, more direct outreach and engagement with growers to help them adopt contamination-reducing practices, and an update to FDA's existing Cyclospora Prevention, Response and Research Action Plan.
FDA frames this explicitly as unfinished business — the agency's own language is that its work on Cyclospora "is far from over," even with both investigations now closed.
Why This Is Worth Tracking
Cyclospora isn't a one-and-done pathogen the way a single contaminated lot can be — it's a recurring, seasonal problem tied to imported fresh produce, and this year's outbreak (over 11,000 illnesses) was large enough that FDA is treating it as a prevention priority heading into next year rather than just closing the file. If you keep an eye on recall news the way I do, this is one to watch again as the 2027 growing season approaches — both for whether the prevention plan actually changes anything, and for whether FDA's promised full Outbreak Investigation Report adds more detail once it's published.
Both FDA notices dated October 2, 2026.